Adiponectin receptor 1 overexpression reduces lipid accumulation and hypertrophy in the heart of diet-induced obese mice-possible involvement of oxidative stress and autophagy

Endocrine Research

Volumn 39, Issue 4, 2014, Pages 173-179

  Chou, I Pin ^a   Chiu, Yao Pang ^a   Ding, Shih Torng ^a   Liu, Bing Hsien ^a   Lin, Yuan Yu ^a   Chen, Ching Yi ^a  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

Adiponectin receptor 1; Autophagy; Diet induced obesity; Hypertrophic heart; Lipid accumulation; Oxidative stress

Indexed keywords

ADIPONECTIN; ADIPONECTIN RECEPTOR 1; BECLIN 1; LYSOSOME ASSOCIATED MEMBRANE PROTEIN 2; SUCROSE; TROPONIN I; ADIPONECTIN RECEPTOR; ADIPONECTIN RECEPTOR 1, MOUSE; APOPTOSIS REGULATORY PROTEIN; BECN1 PROTEIN, MOUSE; BIOLOGICAL MARKER; CD36 ANTIGEN; MANGANESE SUPEROXIDE DISMUTASE; SUGAR INTAKE; SUPEROXIDE DISMUTASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOPHAGY; BECLIN 1 GENE; CONTROLLED STUDY; GENE; GENE OVEREXPRESSION; HEART FUNCTION; HYPERTROPHIC CARDIOMYOPATHY; LAMP 2 A GENE; LEAN BODY WEIGHT; LIPID DIET; LIPID STORAGE; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; OBESITY; OXIDATIVE STRESS; SUGAR INTAKE; TRANSGENE; TRANSGENIC MOUSE; WILD TYPE; ADVERSE EFFECTS; ANIMAL; CARDIOMEGALY; CROSS BREEDING; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENETICS; HEART VENTRICLE; LIPID METABOLISM; METABOLISM; PATHOPHYSIOLOGY; RANDOMIZATION;

ANIMALS; ANTIGENS, CD36; APOPTOSIS REGULATORY PROTEINS; AUTOPHAGY; BIOLOGICAL MARKERS; CARDIOMEGALY; CROSSES, GENETIC; DIET, HIGH-FAT; DIETARY SUCROSE; GENE EXPRESSION REGULATION; HEART VENTRICLES; LIPID METABOLISM; MALE; MICE, TRANSGENIC; OBESITY; OXIDATIVE STRESS; RANDOM ALLOCATION; RECEPTORS, ADIPONECTIN; SUPEROXIDE DISMUTASE; TROPONIN I;

EID: 84911472579     PISSN: 07435800     EISSN: 15324206     Source Type: Journal    
DOI: 10.3109/07435800.2013.879165     Document Type: Article

References (36)

1. Zhang Y, Ren J. Role of cardiac steatosis and lipotoxicity in obesity cardiomyopathy. Hypertension 2011;57:148-50.
2. Finelli C, Tarantino G. What is the role of adiponectin in obesity related non-alcoholic fatty liver disease? World J Gastroenterol 2013;19:802-12.
3. Park M, Sweeney G. Direct effects of adipokines on the heart: focus on adiponectin. Heart Fail Rev 2013;18:631-44.
4. Hug C, Wang J, Ahmad NS, et al. T-cadherin is a receptor for hexameric and high-molecular-weight forms of Acrp30/adiponectin. Proc Natl Acad Sci USA 2004;101:10308-13.
5. Yamauchi T, Kamon J, Ito Y, et al. Cloning of adiponectin receptors that mediate antidiabetic metabolic effects. Nature 2003;423: 762-9.
6. Bjursell M, Ahnmark A, Bohlooly YM, et al. Opposing effects of adiponectin receptors 1 and 2 on energy metabolism. Diabetes 2007;56:583-93.
7. Wang H, Zhang H, Jia Y, et al. Adiponectin receptor 1 gene (ADIPOR1) as a candidate for type 2 diabetes and insulin resistance. Diabetes 2004;53:2132-6.
8. Staiger H, Kaltenbach S, Staiger K, et al. Expression of adiponectin receptor mRNA in human skeletal muscle cells is related to in vivo parameters of glucose and lipid metabolism. Diabetes 2004;53: 2195-201.
9. Guo ZX, Zheng CH, Qin ZH, Wei P. Effect of telmisartan on the expression of cardiac adiponectin and its receptor 1 in type 2 diabetic rats. J Pharm Pharmacol 2011;63:87-94.
10. Liu BH, Lin YY, Wang YC, et al. Porcine adiponectin receptor 1 transgene resists high-fat/sucrose diet-induced weight gain, hepatosteatosis and insulin resistance in mice. Exp Anim 2013;62: 347-60.
11. Chou IP, Lin YY, Ding ST, Chen CY. Adiponectin receptor 1 enhances fatty acid metabolism and cell survival in palmitatetreated HepG2 cells through the PI3 K/AKT pathway. Euro J Nutr 2013. doi: 10.1007/s00394-013-0594-7
12. Li L, Zhang ZG, Lei H, et al. Angiotensin II reduces cardiac AdipoR1 expression through AT1 receptor/ROS/ERK1/2/c-Myc pathway. Plos One 2013;8:e49915.
13. Schmittgen TD, Zakrajsek BA, Mills AG, et al. Quantitative reverse transcription-polymerase chain reaction to study mRNA decay: comparison of endpoint and real-time methods. Anal Biochem 2000;285:194-204.
14. Tarantino G, Savastano S, Colao A. Hepatic steatosis, low-grade chronic inflammation and hormone/growth factor/adipokine imbalance. World J Gastroenterol 2010;16:4773-83.
15. Coort SLM, Bonen A, van der Vusse GJ, et al. Cardiac substrate uptake and metabolism in obesity and type-2 diabetes: role of sarcolemmal substrate transporters. Mol Cell Biochem 2007;299: 5-18.
16. Luiken JJFP, Koonen DPY, Willems J, et al. Insulin stimulates long-chain fatty acid utilization by rat cardiac myocytes through cellular redistribution of FAT/CD, Diabetes 2002;51:3113-9.
17. Ge F, Hu C, Hyodo E, et al. Cardiomyocyte triglyceride accumulation and reduced ventricular function in mice with obesity reflect increased long chain fatty acid uptake and de novo fatty acid synthesis. J Obes 2012;2012:205-648.
18. Mandavia CH, Pulakat L, Demarco V, Sowers JR. Over-nutrition and metabolic cardiomyopathy. Metabolism 2012;61:1205-10.
19. Steinbusch LK, Luiken JJ, Vlasblom R, et al. Absence of fatty acid transporter CD36 protects against Western-type diet-related cardiac dysfunction following pressure overload in mice. Am J Physiol Endocrinol Metab 2011;301:E618-27.
20. Lopaschuk GD, Folmes CD, Stanley WC. Cardiac energy metabolism in obesity. Cir Res 2007;101:335-47.
21. Mazumder PK, O'Neill BT, Roberts MW, et al. Impaired cardiac efficiency and increased fatty acid oxidation in insulin-resistant ob/ob mouse hearts. Diabetes 2004;53:2366-74.
22. Chiu HC, Kovacs A, Ford DA, et al. A novel mouse model of lipotoxic cardiomyopathy. J Clin Invest 2001;107:813-22.
23. Duncan JG, Bharadwaj KG, Fong JL, et al. Rescue of cardiomyopathy in peroxisome proliferator-activated receptor-alpha transgenic mice by deletion of lipoprotein lipase identifies sources of cardiac lipids and peroxisome proliferator-activated receptor-alpha activators. Circulation 2010;121:426-35.
24. Vincent HK, Powers SK, Stewart DJ, et al. Obesity is associated with increased myocardial oxidative stress. Int J Obes 1999;23: 67-74.
25. Ansari JA, Bhandari U, Pillai KK, Haque SE. Effect of rosuvastatin on obesity-induced cardiac oxidative stress in Wistar rats-a preliminary study. Indian J Exp Biol 2012;50:216-22.
26. Ouwens DM, Boer C, Fodor M, et al. Cardiac dysfunction induced by high-fat diet is associated with altered myocardial insulin signalling in rats. Diabetologia 2005;48:1229-37.
27. Rosen ED, Spiegelman BM. Adipocytes as regulators of energy balance and glucose homeostasis. Nature 2006;444:847-53.
28. Nemchenko A, Chiong M, Turer A, et al. Autophagy as a therapeutic target in cardiovascular disease. J Mol Cell Cardiol 2011;51:584-93.
29. Xu X, Ren J. Unmasking the janus faces of autophagy in obesityassociated insulin resistance and cardiac dysfunction. Clin Exp Pharmacol Physiol 2012;39:200-8.
30. Gustafsson AB, Gottlieb RA. Recycle or die: the role of autophagy in cardioprotection. J Mol Cell Cardiol 2008;44:654-61.
31. Li ZL, Woollard JR, Ebrahimi B, et al. Transition from obesity to metabolic syndrome is associated with altered myocardial autophagy and apoptosis. Arter Thromb Vas Biol 2012;32:1132-41.
32. Lee L, Alloosh M, Saxena R, et al. Nutritional model of steatohepatitis and metabolic syndrome in the Ossabaw miniature swine. Hepatology 2009;50:56-67.
33. Neeb ZP, Edwards JM, Alloosh M, et al. Metabolic syndrome and coronary artery disease in Ossabaw compared with Yucatan swine. Comp Med 2010;60: 300-15.
34. Cowherd RB, Asmar MM, Alderman JM, et al. Adiponectin lowers glucose production by increasing SOGA. Am J Pathol 2010;177: 1936-45.
35. Pineiro R, Iglesias MJ, Gallego R, et al. Adiponectin is synthesized and secreted by human and murine cardiomyocytes. Febs Lett 2005;579:5163-9.
36. Amin RH, Mathews ST, Alli A, Leff T. Endogenously produced adiponectin protects cardiomyocytes from hypertrophy by a PPAR gamma-dependent autocrine mechanism. Am J Physiol Heart Circ Physiol 2010;299:H690-8.